Factor XIa: Difference between revisions

Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
 
(6 intermediate revisions by the same user not shown)
Line 1: Line 1:
<StructureSection load='1zmn' size='350' side='right' scene='' caption='Human factor XIa catalytic domain complex with aryl boronic acid derivative and sulfate (PDB code [[1zmn]])'>
<StructureSection load='1zmn' size='350' side='right' scene='' caption='Human factor XIa catalytic domain complex with aryl boronic acid derivative and sulfate (PDB code [[1zmn]])'>
[[Image:Coag_cartoon.jpg |left| thumb |450px| Schematic representation of the coagulation response]]
[[Image:Coag_cartoon.jpg |left| thumb |300px| Schematic representation of the coagulation response]]
{{Clear}}
{{Clear}}
__TOC__
==Coagulation Factor XIa==
==Coagulation Factor XIa==
===Introduction===
===Introduction===
Line 83: Line 84:


Amino acid substitutions such as Phe283Leu<ref>PMID:17257616</ref> and Gly350Glu<ref>PMID:15026311 </ref> in the heavy chain results in an increased dimer dissociation and absence of dimer formation respectively. Some mutations in the factor XI A4 domain and catalytic domains are inherited as autosomal recessive bleeding diathesis however, other amino acid substitutions are exert a dominant negative effect on the normal monomer subunit affecting protein secretion. Studies suggest that dimerization is not affected under dominant negative mutations but the mutant subunit traps the normal subunit in the cell preventing its secretion. Majority of these missense mutations:Ser225Phe, Cys398Tyr, Gly400Val and Trp569Ser which produce a dominant negative effect involves residues found in the catalytic domain<ref>PMID:15026311 </ref>.
Amino acid substitutions such as Phe283Leu<ref>PMID:17257616</ref> and Gly350Glu<ref>PMID:15026311 </ref> in the heavy chain results in an increased dimer dissociation and absence of dimer formation respectively. Some mutations in the factor XI A4 domain and catalytic domains are inherited as autosomal recessive bleeding diathesis however, other amino acid substitutions are exert a dominant negative effect on the normal monomer subunit affecting protein secretion. Studies suggest that dimerization is not affected under dominant negative mutations but the mutant subunit traps the normal subunit in the cell preventing its secretion. Majority of these missense mutations:Ser225Phe, Cys398Tyr, Gly400Val and Trp569Ser which produce a dominant negative effect involves residues found in the catalytic domain<ref>PMID:15026311 </ref>.
==3D structures of Factor XIa==
[[Factor XIa 3D structures]]
</StructureSection>
</StructureSection>
__NOTOC__
==3D structures of Factor XIa==
Updated on {{REVISIONDAY2}}-{{MONTHNAME|{{REVISIONMONTH}}}}-{{REVISIONYEAR}}
{{#tree:id=OrganizedByTopic|openlevels=0|
*Factor XIa
**[[2j8j]], [[2j8l]] – hFXIa A4 domain (residues 290-379) – human – NMR<br />
**[[2f83]] - hFXIa zymogen (residues 1-625)
*Factor XIa light chain catalytic domain (residues 388-625) inhibitor complex


**[[3bg8]] – hFXIa + clavatadine<br />
**[[1zpb]], [[2fda]] - hFXIa (mutant) + ketothiazole inhibitor<br />
**[[4na7]], [[4na8]], [[4y8x]] - hFXIa + inhibitor<br />
**[[4y8z]] - hFXIa + quinoline inhibitor<br />
**[[5e2o]], [[5exm]], [[5tkt]] - hFXIa (mutant) + inhibitor<br />
**[[4cr5]], [[4cr9]], [[4cra]], [[4crb]], [[4cre]], [[4crf]], [[1ztl]], [[4ty7]], [[4wxi]], [[4d7g]], [[5e2p]] - hFXIa (mutant) + quinolin inhibitor<br />
**[[4y8y]] - hFXIa + tetrazol inhibitor<br />
**[[4crc]], [[4crd]], [[3sor]], [[1zpc]], [[3sos]], [[4x6o]], [[5exn]], [[5tku]] - hFXIa (mutant) + tetrazol inhibitor<br />
**[[4crg]] - hFXIa (mutant) + pyrimidine inhibitor<br />
**[[1ztk]], [[1ztj]], [[1zsl]] - hFXIa (mutant) + pyrimidinone inhibitor<br />
**[[4x6m]], [[4x6p]], [[5exl]] - hFXIa (mutant) + indazole inhibitor<br />
**[[4x6n]] - hFXIa (mutant) + indazole inhibitor + peptide<br />
**[[1zhm]], [[1zhp]], [[1zhr]] - hFXIa (mutant) + benzamidine inhibitor<br />
**[[1zrk]], [[1zsk]], [[1zsj]] - hFXIa (mutant) + naphthamidine inhibitor<br />
**[[1zpz]], [[1zom]] - hFXIa (mutant) + peptidomimetic inhibitor<br />
**[[1zmn]], [[1zml]], [[1zmj]], [[1zlr]] - hFXIa (mutant) + aryl boronic acid inhibitor<br />
**[[1zjd]] - hFXIa (mutant) + Kunitz protease inhibitory domain<br />
**[[1xx9]] - hFXIa + ecotin (mutant)<br />
**[[1xxd]], [[1xxf]] - hFXIa (mutant) + ecotin (mutant)<br />
**[[4ty6]] - hFXIa light chain (mutant) + heavy chain peptide + benzamine inhibitor<br />
}}
==References==
==References==
<references />
<references />


[[Category:Topic Page]]
[[Category:Topic Page]]

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

Francis Ayombil, Michal Harel, Alexander Berchansky